| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 79 / 100 | 21st | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Genetic Testing and Molecular Biomarkers
Genetic Testing and Molecular Biomarkers is Scopus-indexed (Q4, CiteScore 1.9), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1945-0257Verify ISSN ↗1945-0265Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Genetic Testing and Molecular Biomarkers indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q4, CiteScore 1.9.
What quartile is Genetic Testing and Molecular Biomarkers in Scopus?
Genetic Testing and Molecular Biomarkers is Q4 in Genetics (clinical) (rank 79 of 100), by CiteScore 2025.
What is the impact factor of Genetic Testing and Molecular Biomarkers?
Genetic Testing and Molecular Biomarkers is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.9, which places it in quartile Q4 at the 21st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.302, quartile Q3, with an H-index of 56.
Who publishes Genetic Testing and Molecular Biomarkers and what is its ISSN?
Genetic Testing and Molecular Biomarkers is published by SAGE Publications Ltd. Its print ISSN is 1945-0257 and its online ISSN is 1945-0265.
Is Genetic Testing and Molecular Biomarkers in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Genetic Testing and Molecular Biomarkers open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Genetic Testing and Molecular Biomarkers? — open metrics via OpenAlex
Genetic Testing and Molecular Biomarkers has an h-index of 51 and a 2-year mean of 1.17 citations per paper (OpenAlex). Its Scopus CiteScore is 1.9, quartile Q4. On 2-year citations it ranks #72 of 99 Scopus journals in Genetics (clinical).
Genetic Testing and Molecular Biomarkers published 44 papers in 2025; its busiest recent year was 2019 with 125. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Genetic Testing and Molecular Biomarkers? — latest 99 articles, 2024–2026
In its latest 99 research articles (2024–2026), authors are most often from China (36.4%), Iran (20.2%) and India (6.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Genetic Testing and Molecular Biomarkers? — indicators, not proof of misconduct
Scopus status: Active. 12 retracted papers are recorded (5.6 per 1,000 papers). The Problematic Paper Screener flags 7 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 12 · 5.6 per 1,000 papers
- Problematic Paper Screener flags 7 · 3.3 per 1,000 papers — mostly suspect text
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.